American Shared Hospital Services (AMS) risk factors, FY2024 10-K

American Shared Hospital Services's FY2024 10-K, filed Apr 04, 2025, lists 24 risk factors. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
241 groups
Section length
6k wordsItem 1A

American Shared Hospital Services's biggest risks in the FY2024 10-K

  • The business relies heavily on Gamma Knife units and a limited customer base.
  • Substantial debt and credit agreements constrain operational flexibility.
  • International expansion exposes operations to foreign exchange and regulatory risks.

The risks most specific to American Shared Hospital Services

  • If the Company is not successful at diversifying its business model, its revenues and profitability may decline

    The Company relies historically on Gamma Knife unit placement and PBRT systems, and needs to successfully diversify through the RI Acquisition.

  • The Federal reimbursement rate for Gamma Knife treatments may not provide the Company with an adequate return on its investment

    Congress reduced Medicare reimbursement rates for outpatient Gamma Knife treatments in 2013, impacting investment returns.

  • The Company has incurred debt and may incur additional debt to finance its operations and if the Company is unable to secure additional credit in the future its operations and profits will be negatively impacted

    The Company entered into a $22,000,000 credit agreement with Fifth Third on April 9, 2021, to refinance its domestic portfolio and debt.

  • The Company’s failure to file certain financial statements in connection with the RI Acquisition pursuant to Rules 8-04 and 8-05 of Regulation S-X and Item 9.01 of Form 8-K will limit the Company’s ability to raise capital

    On May 7, 2024, the Company acquired a 60% equity interest in the RI Companies from GenesisCare, risking capital-raising limits if financial statements under Regulation S-X are not filed.

  • If the Company is not successful in addressing these risks effectively, the Company’s business and operations could be impaired

    The Company faces material weaknesses in internal control over financial reporting, impairing its ability to report financial conditions accurately.

  • A small number of customers account for a major portion of our revenues and the loss of any one of these significant customers could have a material adverse effect on the Company's business and results of operations

    Two major customers accounted for approximately 35% and 27% of the Company's revenue in 2024.

  • International operations make the Company vulnerable to risks associated with doing business in foreign countries that can affect its business, financial condition, results of operations and cash flows

    International operations in Lima, Peru, Guayaquil, Ecuador, and Puebla, Mexico subject the Company to foreign exchange volatility.

  • The potential impairment of our Gamma Knife portfolio and its salvage value could adversely impact our financial condition and results of operations

    As of December 31, 2024, the Gamma Knife portfolio has no remaining salvage value, and certain sites experienced equipment impairment.

All 24 risk factors

Headings as the filing states them, in filing order.

Other

  1. 01If the Company is not successful at diversifying its business model, its revenues and profitability may decline
  2. 02The Federal reimbursement rate for Gamma Knife treatments may not provide the Company with an adequate return on its investment
  3. 03The Company's revenue sharing is subject to payor mix variability which could negatively impact the Company's revenue and financial results
  4. 04The Company’s capital investment at each site is substantial and the Company may not be able to fully recover its costs or capital investment which could have a material negative impact on its revenues and financial results
  5. 05The market for the Gamma Knife is limited and the Company may not be able to place additional Gamma Knife units which could negatively impact the Company's revenue and financial results
  6. 06The Company has incurred debt and may incur additional debt to finance its operations and if the Company is unable to secure additional credit in the future its operations and profits will be negatively impacted
  7. 07The Company’s debt agreements contain restrictions that limit its flexibility in operating its business, and the Company may be required to repay the outstanding indebtedness in an event of default, which would have an adverse effect on our business
  8. 08The Company’s failure to file certain financial statements in connection with the RI Acquisition pursuant to Rules 8-04 and 8-05 of Regulation S-X and Item 9.01 of Form 8-K will limit the Company’s ability to raise capital
  9. 09If the Company is not successful in addressing these risks effectively, the Company’s business and operations could be impaired
  10. 10The Company’s cash flow could become insufficient to service its debt due to financial, business, and other factors
  11. 11A small number of customers account for a major portion of our revenues and the loss of any one of these significant customers could have a material adverse effect on the Company's business and results of operations
  12. 12The Company occupies many of its facilities under long-term leases and the Company may not be able to renew its leases at the end of their terms
  13. 13The market for the Company’s services is competitive and if the Company is not able to compete its business and results of operations could be negatively impacted
  14. 14There are alternatives to the Gamma Knife and medical centers could choose to use other radiosurgery devices instead of the Gamma Knife
  15. 15International operations make the Company vulnerable to risks associated with doing business in foreign countries that can affect its business, financial condition, results of operations and cash flows
  16. 16Flaws in the Company’s due-diligence assessment in connection with the equity interests and payor contracts acquired in the RI Acquisition could have a significant negative effect on the Company’s financial condition and results of operations
  17. 17New technology and products could result in making the Company's equipment obsolete which could have a material adverse impact on its business and results of operations
  18. 18Macroeconomic conditions could have a material adverse effect on our business, results of operations, and financial condition
  19. 19We are subject to risks associated with foreign operations, including political, economic, and regulatory uncertainties
  20. 20The potential impairment of our Gamma Knife portfolio and its salvage value could adversely impact our financial condition and results of operations

Stock Ownership Risk

  1. 21The trading volume of the Company’s common stock is low
  2. 22Our officers, directors and principal shareholders collectively own a substantial portion of our common stock
  3. 23our corporate financing activities
  4. 24We do not anticipate paying dividends on our common stock

Other American Shared Hospital Services 10-Ks

  • FY2025 10-K risk factors
    24 risks4 new4 dropped5 reworded

    Going concern doubts and covenant defaults dominate the risk section following debt acceleration risks and liquidity issues.

    Filed Mar 31, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.